News Media Group Partners with Smart Shopping Expert Trae Bodge to Launch Aiper Day Pool Savings Campaign
West Palm Beach, Florida--(Newsfile Corp. - June 12, 2025) - As the summer pool season heats up, News Media Group, Inc. partnered with Smart Shopping Expert Trae Bodge and Aiper, the pioneer of cordless, robotic pool cleaners. This collaboration featured a nationwide media tour spotlighting 'Aiper Day,' one of the brand's biggest sales of the year, running now until the end of June.
[ This video cannot be displayed. Please visit the source: https://www.youtube.com/v/CiHPR5nYHMQ ]
Cannot view this video? Visit:
https://www.youtube.com/watch?v=CiHPR5nYHMQ
Trae Bodge featured Aiper's flagship product, the Scuba X1 Pro Max, an all-in-one cordless robotic cleaner that effortlessly scrubs pool floors, walls, waterlines, and even skims the surface, helping consumers save significant time on maintenance. Among all the pool tech deals, the tour emphasized the $600 savings on the Scuba X1 Pro Max during Aiper Day, along with even more saving opportunities to bundle it with Aiper's HydroComm Pro for enhanced underwater communication, water quality monitoring, and app control, offering pool owners premium tech at an exceptional value.
Pool owners can find out more about Aiper Day sales by visiting the website www.Aiper.com.
Media Contact Details:
Karl Wayne
Executive Producer/Partner
News Media Group, Inc.
[email protected]
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/255270
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Miami Herald
an hour ago
- Miami Herald
Dispatch Ranks on Inc. 5000 List for Fourth Consecutive Year, Recognizing Exceptional Growth and Innovation
Dispatch continues to scale last-mile logistics through strategic investments in AI, talent, and customer success. BLOOMINGTON, MN / ACCESS Newswire / August 13, 2025 / Dispatch is proud to announce its inclusion on the 2025 Inc. 5000 list of America's fastest-growing private companies for the fourth consecutive year. This prestigious recognition highlights Dispatch's sustained growth and technological innovation within the highly competitive logistics and transportation sector. "Being named to the Inc. 5000 once again is an incredible achievement and speaks to our ongoing commitment to scaling last-mile delivery for businesses of all sizes," said Andrew Leone, CEO and Co-Founder of Dispatch. "This recognition reflects the hard work our team has invested in expanding our capabilities, particularly in areas like AI, company culture, and customer retention. As the industry continues to evolve, we remain focused on driving impactful change in the logistics space." Key Growth Drivers Over the past year, Dispatch has experienced significant growth, driven by strategic investments in technology, talent, and customer success. The company has expanded its AI-driven solutions, enabling an efficient and scalable last-mile delivery platform for businesses across various industries. Dispatch has also strengthened its team, focusing on fostering a positive culture and promoting internal talent, which has been critical to maintaining operational excellence. As a result, Dispatch has seen a remarkable increase in both its customer base and revenue, with a 68% three-year growth rate. Inc. Methodology Companies on the 2025 Inc. 5000 are ranked according to percentage revenue growth from 2021 to 2024. To qualify, companies must have been founded and generating revenue by March 31, 2021. They must be U.S.-based, privately held, for-profit, and independent - not subsidiaries or divisions of other companies - as of December 31, 2024. (Since then, some on the list may have gone public or been acquired.) The minimum revenue required for 2021 is $100,000; the minimum for 2024 is $2 million. As always, Inc. reserves the right to decline applicants for subjective reasons. For the full Inc. 5000 list, visit: About Inc.: Inc. is the leading media brand and playbook for the entrepreneurs and business leaders shaping our future. Through its journalism, Inc. aims to inform, educate, and elevate the profile of its community: the risk-takers, the innovators, and the ultra-driven go-getters who are creating the future of business. Inc. is published by Mansueto Ventures LLC, along with fellow leading business publication Fast Company. For more information, visit About Dispatch: Dispatch is redefining last-mile delivery for the modern business. As the premier B2B delivery platform, Dispatch empowers organizations with scalable, technology-driven solutions that streamline logistics, enhance visibility, and improve customer satisfaction. Through its robust delivery management software, seamless API integrations, and a reliable network of independent contractor drivers, Dispatch enables businesses of all sizes to simplify and optimize their last-mile operations. Media Contact: For more information about Dispatch, please contact the media representative at: Email: pr@
Business Wire
an hour ago
- Business Wire
bioAffinity Technologies Announces Pricing of Private Placement and Warrant Inducement Transaction for Approximately $1.2 Million in Gross Proceeds
SAN ANTONIO--(BUSINESS WIRE)-- bioAffinity Technologies, Inc. (NASDAQ: BIAF, BIAFW), a biotechnology company focused on the need for noninvasive tests for the detection of early-stage cancer, today announced that it has entered into securities purchase agreements with several institutional and accredited investors (the "Purchasers") for the purchase and sale of 990 shares of the Company's Series B Convertible Preferred Stock (the 'Preferred Stock') and warrants (the 'Private Placement Warrants') to purchase approximately 6.7 million shares of common stock (the 'Private Placement'). The Company shall use the net proceeds from the Private Placement and Warrant Inducement for working capital and general corporate purposes. The shares of Preferred Stock have a stated value of $1,000 per share and are initially convertible into an aggregate of approximately 4.3 million shares of common stock at a conversion price of $0.23 per share. The Private Placement Warrants will be exercisable following the date on which the Company obtains stockholder approval of the exercise thereof at an initial exercise price of $0.352 per share and expire five years from the original exercise date. The Company also announced today it has entered into a warrant exercise agreement with an existing accredited investor to exercise (i) outstanding warrants to purchase 450,000 shares of the Company's shares of common stock that were issued in August 2024 (the 'August Warrants') and (ii) outstanding warrants to purchase 650,000 shares of the Company's common stock that were issued in October 2024 (the 'October Warrants' and together with the August Warrants, the 'Existing Warrants'), which reduced the exercise prices of the August Warrants from $1.50 to $0.23 per share and the October Warrants from $1.25 to $0.23 per share and provided for the issuance to such investor of new unregistered warrants (the 'New Warrants') to purchase up to an aggregate of 1.43 million shares of the Company's common stock in consideration for the immediate exercise in full of the Existing Warrants for gross cash proceeds to the Company of approximately $253,000 (the 'Warrant Inducement'). The New Warrants will have an exercise price of $0.352 per share and will be initially exercisable on the date that stockholder approval of the exercise of the New Warrants is obtained and will expire five years from the date of such approval. The closing of the Private Placement and Warrant Inducement is expected to occur on or about August 14, 2025, subject to the satisfaction of customary closing conditions. The expected aggregate proceeds (before expenses) of the Private Placement and Warrant Inducement will be approximately $1.2 million. The Company shall use the net proceeds from the Private Placement and Warrant Inducement for working capital and general corporate purposes. WallachBeth Capital LLC is acting as the sole placement agent for the Private Placement and financial advisor for the Warrant Inducement. The securities described above will be offered in a private placement exempt from the registration requirements under Section 4(a)(2) of the Securities Act of 1933, as amended (the "Act") and Regulation D promulgated thereunder and in a transaction not involving a public offering and have not been registered under the Act or applicable state securities laws. Accordingly, the securities may not be reoffered or resold in the United States except pursuant to an effective registration statement or an applicable exemption from the registration requirements of the Act and such applicable state securities laws. The Company has agreed to file a registration statement with the SEC covering the resale of the shares of common stock underlying the Preferred Stock, the Private Placement Warrants and New Warrants within 15 calendar days after the closing date. This press release shall not constitute an offer to sell or a solicitation of an offer to buy any of the securities described herein, nor shall there be any sale of these securities in any state or other jurisdiction in which such offer, solicitation or sale would be unlawful prior to the registration or qualification under the securities laws of any such state or other jurisdiction. About CyPath® Lung CyPath ® Lung uses proprietary advanced flow cytometry and artificial intelligence (AI) to identify cell populations in patient sputum that indicate malignancy. Automated data analysis helps determine if cancer is present or if the patient is cancer-free. CyPath® Lung incorporates a fluorescent porphyrin that is preferentially taken up by cancer and cancer-related cells. Clinical study results demonstrated that CyPath® Lung had 92% sensitivity, 87% specificity and 88% accuracy in detecting lung cancer in patients at high risk for the disease who had small lung nodules less than 20 millimeters. Diagnosing and treating early-stage lung cancer can improve outcomes and increase patient survival. For more information, visit About bioAffinity Technologies, Inc. bioAffinity Technologies, Inc. addresses the need for noninvasive diagnosis of early-stage cancer and other diseases of the lung and broad-spectrum cancer treatments. The Company's first product, CyPath® Lung, is a noninvasive test that has shown high sensitivity, specificity and accuracy for the detection of early-stage lung cancer. CyPath® Lung is marketed as a Laboratory Developed Test (LDT) by Precision Pathology Laboratory Services, a subsidiary of bioAffinity Technologies. For more information, visit Forward-Looking Statements Certain statements in this press release constitute "forward-looking statements" within the meaning of the federal securities laws. Words such as "may," "might," "will," "should," "believe," "expect," "anticipate," "estimate," "continue," "predict," "forecast," "project," "plan," "intend" or similar expressions, or statements regarding intent, belief, or current expectations, are forward-looking statements. These forward-looking statements are based upon current estimates and assumptions and include statements regarding the closing of the offering on August 14, 2025. These forward-looking statements are subject to various risks and uncertainties, many of which are difficult to predict, that could cause actual results to differ materially from current expectations and assumptions from those set forth or implied by any forward-looking statements. Important factors that could cause actual results to differ materially from current expectations include, among others, the ability to close the offering when anticipated and the risk factors discussed in the Company's Annual Report on Form 10-K for the year ended December 31, 2024, and its subsequent filings with the SEC, including subsequent periodic reports on Forms 10-Q and 8-K. Such forward-looking statements are based on facts and conditions as they exist at the time such statements are made and predictions as to future facts and conditions. While the Company believes these forward-looking statements are reasonable, readers of this press release are cautioned not to place undue reliance on any forward-looking statements. The information in this release is provided only as of the date of this release, and the Company does not undertake any obligation to update any forward-looking statement relating to matters discussed in this press release, except as may be required by applicable securities laws.
Business Wire
an hour ago
- Business Wire
CheckedUp Named to Inc. 5000 List of America's Fastest-Growing Companies for 4
NEW YORK--(BUSINESS WIRE)--CheckedUp, the fastest-growing digital Point of Care company transforming patient and provider engagement, today announced its fourth appearance on the 2025 Inc. 5000 list, the most prestigious ranking of the fastest-growing private companies in America. The list provides a data-driven snapshot of the most successful companies within the economy's most dynamic segment—its independent, entrepreneurial businesses. Past honorees include Microsoft, Meta, Chobani, Under Armour, Timberland, Oracle, and Patagonia. 'I am honored that CheckedUp has again landed a coveted spot on this list of the fastest-growing private companies in the nation,' said Dr. Richard Awdeh, CEO and Co-Founder of CheckedUp. 'Earning this recognition for the fourth time is a testament to the relentless dedication, creativity, and passion of our world-class team. We remain committed to delivering innovative Point of Care solutions that help our partners achieve measurable impact.' Mark Awdeh, President and Co-Founder of CheckedUp, added, 'Making the Inc. 5000 list once is a huge accomplishment for any company, and to have made it for the fourth time makes me incredibly proud. Our growth reflects our ability to adapt, innovate, and deliver unmatched value for our clients—and we believe the best is yet to come.' This year's Inc. 5000 honorees have demonstrated exceptional growth while navigating economic uncertainty, inflationary pressure, and a fluctuating labor market. 'Making the Inc. 5000 is always a remarkable achievement, but earning a spot this year speaks volumes about a company's tenacity and clarity of vision,' says Mike Hofman, editor-in-chief of Inc. 'These businesses have thrived amid rising costs, shifting global dynamics, and constant change. They didn't just weather the storm—they grew through it, and their stories are a powerful reminder that the entrepreneurial spirit is the engine of the U.S. economy.' Under the leadership of Dr. Richard Awdeh and Mark Awdeh, CheckedUp has become a leader in digital, specialty-focused Point of Care solutions. Over the past three years, the company has doubled the size of its network, expanded its suite of patient engagement tools, and strengthened its ability to reach patients and HCPs with precision through data-driven, technology-enabled campaigns. This growth has allowed CheckedUp to offer an increasingly valuable Point of Care network to its customers, further solidifying its position at the forefront of the industry. For the full list, company profiles, and a searchable database by industry and location, visit: About CheckedUp CheckedUp is a physician-founded digital Point of Care company dedicated to delivering specialty-specific education and engagement tools that actively involve patients, caregivers, and physicians at critical moments in the care journey. As one of the nation's largest 100% digital, specialty-focused Point of Care networks, CheckedUp operates a robust national footprint that reaches patients through condition-specific content across multiple digital touchpoints—including waiting room TVs and interactive exam room wallboards in specialty healthcare provider offices and hospital systems across the U.S. Through its advanced technology platform, enhances the patient experience, empowers provider communication, and drives measurable outcomes in clinical settings. In 2022, the company acquired Health Media Network and its affiliated properties. CheckedUp is backed by Rockbridge Growth Equity. About Inc. and the Inc. 5000 Methodology Companies on the 2025 Inc. 5000 are ranked according to percentage revenue growth from 2021 to 2024. To qualify, companies must have been founded and generating revenue by March 31, 2021. They must be U.S.-based, privately held, for-profit, and independent—not subsidiaries or divisions of other companies—as of December 31, 2024. (Since then, some on the list may have gone public or been acquired.) The minimum revenue required for 2021 is $100,000; the minimum for 2024 is $2 million. As always, Inc. reserves the right to decline applicants for subjective reasons. About Inc. Inc. is the leading media brand and playbook for the entrepreneurs and business leaders shaping our future. Through its journalism, Inc. aims to inform, educate, and elevate the profile of its community: the risk-takers, the innovators, and the ultra-driven go-getters who are creating the future of business. Inc. is published by Mansueto Ventures LLC, along with fellow leading business publication Fast Company. For more information, visit
